Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-03

Clinical Trial Update: Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia [NA]

View source ↗

Summary

A completed clinical trial evaluated the combination of dexmedetomidine with low-dose nalmefene for preventing remifentanil-induced postoperative hyperalgesia; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Nalmefene (nalmefene)
  • Remifentanil (remifentanil)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Pain, Anesthesia | NA | Status: COMPLETED | Results posted: 2021-08-03